ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Hawaii » Psychiatry

Top Psychiatry Prescribers in Hawaii

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KIMBERLY CHARLTON M.D.

Psychiatry

452

$171K

42
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

48%
prescriptions for brand name drugs

Avg: 26%

$379
Average prescription price

Avg: $177

SHALINI MISHRA M.D.

Psychiatry

1,403

$425K

57
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

40%
prescriptions for brand name drugs

Avg: 26%

$303
Average prescription price

Avg: $177

MICHAEL ZAFRANI MD

Psychiatry

1,972

$584K

112
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

35%
prescriptions for brand name drugs

Avg: 26%

$296
Average prescription price

Avg: $177

ANTONIA AUSTRIA M.D.

Psychiatry

1,056

$297K

54
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 26%

$281
Average prescription price

Avg: $177

EVARTS FOX M.D.

Psychiatry

1,111

$294K

66
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

33%
prescriptions for brand name drugs

Avg: 26%

$265
Average prescription price

Avg: $177

HAROLD GOLDBERG MD

Psychiatry

1,448

$380K

131
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

36%
prescriptions for brand name drugs

Avg: 26%

$262
Average prescription price

Avg: $177

PETER YAMAMOTO M.D.

Psychiatry

1,675

$424K

64
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

33%
prescriptions for brand name drugs

Avg: 26%

$253
Average prescription price

Avg: $177

GLORIFIN BELMONTE M.D.

Psychiatry

2,548

$620K

92
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

33%
prescriptions for brand name drugs

Avg: 26%

$243
Average prescription price

Avg: $177

DAVID STEIN M.D.

Psychiatry

1,481

$347K

65
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 26%

$235
Average prescription price

Avg: $177

PETER IN M.D.

Psychiatry

938

$216K

56
18 are 65+

34%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 26%

$230
Average prescription price

Avg: $177

DORIS ROSS MD

Psychiatry

740

$166K

49
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 26%

$224
Average prescription price

Avg: $177

KEN MATSUMOTO M.D.

Psychiatry

2,169

$481K

99
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 26%

$222
Average prescription price

Avg: $177

CAROL MINN M.D.

Psychiatry

1,321

$292K

49
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 26%

$221
Average prescription price

Avg: $177

MARVA LAWSON MD

Psychiatry

722

$158K

43
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 26%

$219
Average prescription price

Avg: $177

JB SAMPSELL MD

Psychiatry

1,995

$436K

133
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 26%

$218
Average prescription price

Avg: $177

ALAN BUFFENSTEIN M.D

Psychiatry

3,227

$695K

137
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 26%

$215
Average prescription price

Avg: $177

THI NGOC TRAN M.D.

Psychiatry

2,154

$442K

97
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

19%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 26%

$205
Average prescription price

Avg: $177

DENIS MEE-LEE MD

Psychiatry

3,475

$698K

182
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 26%

$201
Average prescription price

Avg: $177

ANNE VIRNIG M.D.

Psychiatry

652

$130K

21
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

35%
prescriptions for brand name drugs

Avg: 26%

$199
Average prescription price

Avg: $177

KATHLEEN IANNITELLO M.D.

Psychiatry

1,097

$217K

65
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 26%

$198
Average prescription price

Avg: $177

MICHAEL MCGRATH M.D.

Psychiatry

422

$83.2K

63
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 26%

$197
Average prescription price

Avg: $177

SHELLEY HAM M.D.

Psychiatry

1,153

$224K

61
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

33%
prescriptions for brand name drugs

Avg: 26%

$194
Average prescription price

Avg: $177

JOSEPH GIANNASIO M.D.

Psychiatry

2,008

$376K

143
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 26%

$187
Average prescription price

Avg: $177

BARRY WORCHEL M.D.

Psychiatry

696

$128K

41
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 26%

$184
Average prescription price

Avg: $177

EDMUND VALERIO MD

Psychiatry

433

$79.4K

17
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 26%

$183
Average prescription price

Avg: $177

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank